Butyzamide
Butyzamide is an orally active activator of Mpl, a thrombopoietin (TPO) receptor. Butyzamide increases the phosphorylation level of JAK2, STAT3, STAT5 and MAPK. Butyzamide increases the level of platelets in mouse xenotransplantation assay[1].
Product Specifications
CAS Number
1110767-45-7
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
JAK; p38 MAPK; STAT
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/butyzamide.html
Purity
99.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCOC(C(C)(C)C)C1=CC=CC(C2=CSC(NC(C3=CC(Cl)=C(/C=C(C(O)=O)\C)C(Cl)=C3)=O)=N2)=C1OC
Molecular Formula
C29H32Cl2N2O5S
Molecular Weight
591.55
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK2; STAT3; STAT5
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-imino-2-phenazinamine Hydrochloride
GLEPP1 (PTPRO) (NM_030671) Human Recombinant Protein
HSP27 (HSPB1) (C-term) Rabbit Polyclonal Antibody
